Source: Biomedicine and Pharmacotherapy. Unidade: ICB
Subjects: FARMACOLOGIA, ANATOMIA, CÉLULAS CULTIVADAS DE TUMOR, CAMUNDONGOS, NEOPLASIAS RENAIS, FATORES DE TRANSCRIÇÃO, WESTERN BLOTTING, REAÇÃO EM CADEIA POR POLIMERASE, PULMÃO
ABNT
BRAGA, Marina de Souza et al. Involvement of the NF-kB/p50/Bcl-3 complex in response to antiangiogenic therapy in a mouse model of metastatic renal cell carcinoma. Biomedicine and Pharmacotherapy, v. 68, n. 7, p. 873-879, 2014Tradução . . Disponível em: https://doi.org/10.1016/j.biopha.2014.07.008. Acesso em: 04 out. 2024.APA
Braga, M. de S., Paiva, K. B. da S., Foguer, K., Chaves, K. C. B., Lima, L. de S., Scavone, C., & Bellini, M. H. (2014). Involvement of the NF-kB/p50/Bcl-3 complex in response to antiangiogenic therapy in a mouse model of metastatic renal cell carcinoma. Biomedicine and Pharmacotherapy, 68( 7), 873-879. doi:10.1016/j.biopha.2014.07.008NLM
Braga M de S, Paiva KB da S, Foguer K, Chaves KCB, Lima L de S, Scavone C, Bellini MH. Involvement of the NF-kB/p50/Bcl-3 complex in response to antiangiogenic therapy in a mouse model of metastatic renal cell carcinoma [Internet]. Biomedicine and Pharmacotherapy. 2014 ; 68( 7): 873-879.[citado 2024 out. 04 ] Available from: https://doi.org/10.1016/j.biopha.2014.07.008Vancouver
Braga M de S, Paiva KB da S, Foguer K, Chaves KCB, Lima L de S, Scavone C, Bellini MH. Involvement of the NF-kB/p50/Bcl-3 complex in response to antiangiogenic therapy in a mouse model of metastatic renal cell carcinoma [Internet]. Biomedicine and Pharmacotherapy. 2014 ; 68( 7): 873-879.[citado 2024 out. 04 ] Available from: https://doi.org/10.1016/j.biopha.2014.07.008